Getinge AB (OTCPK:GNGBF)
$ 17.85 0 (0%) Market Cap: 4.95 Bil Enterprise Value: 5.58 Bil PE Ratio: 29.80 PB Ratio: 1.49 GF Score: 86/100

Q4 2023 Getinge AB Earnings Call Transcript

Feb 01, 2024 / 09:00AM GMT
Release Date Price: $19 (-9.57%)
Mattias Perjos;publ;President;CEO
Getinge AB

()-&

Thank you very much, and welcome, everyone, to today's conference. I have Lars Sandström with me here today, and he will do the deep dive into the financials and also help with the Q&A a bit later. But we can move directly into page number 2 to look at the key takeaways for the fourth quarter of last year.

In terms of sales, getting us to net sales increased by 16.5% in the fourth quarter, and this is following growth in all business areas and regions. Organic growth accounted for 10.1% of these acquisitions for 5% and currency for one point, our order intake increased by 4.1% in the quarter, driven by acquisitions and currency. Organically, it decreased by 2.4%, which is mainly due to the challenging comparative figures from 2022 in connection with China lifting its COVID-19 restrictions back then.

Despite the increased sales, the adjusted EBITA margin was lower than last year, mainly due to the quality cost for the improvement work in Acute Care Therapies that we've had since the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot